Challenges in defining inappropriate medication use in Parkinson’s dementia
In a recent editorial in JAMA Neurology, a group of neurologists at The Fixel Center for Neurological Diseases at UF Health — Christopher Hess, M.D., Michael Okun, M.D., and Adolfo Ramirez-Zamora, M.D. — discuss the challenges in defining inapporpriate medication use in Parkinson’s disease dementia.
“National prescribing trends for patients with Parkinson disease and dementia are not well studied in the United States, and available data often exclude geographic location, race/ethnicity, and sex. In this editorial, we review the findings of the study by Mantri et al1 regarding patterns of antidementia medication use, and we address the challenges in defining and studying inappropriate medication prescribing in Parkinson disease,” the authors state.